The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A review of computational drug repurposing
Open accessAbstract
Although sciences and technology have progressed rapidly, de novo drug development has been a costly and time-consuming process over the past decades. In view of these circumstances, 'drug repurposing' (or 'drug repositioning') has appeared as an alternative tool to accelerate drug development process by seeking new indications for already approved drugs rather than discovering de novo drug compounds, nowadays accounting for 30% of newly marked drugs in the U.S. In the meantime, the explosive and large-scale growth of molecular, genomic and phenotypic data of pharmacological compounds is enabling the development of new area of drug repurposing called computational drug repurposing. This review provides an overview of recent progress in the area of computational drug repurposing. First, it summarizes available repositioning strategies, followed by computational methods commonly used. Then, it describes validation techniques for repurposing studies. Finally, it concludes by discussing the remaining challenges in computational repurposing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
NCBI GEO: mining millions of expression profiles--database and tools
Barrett, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki022 · Cited by 1,206
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Validating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
Network-based in silico drug efficacy screening
Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016) · Nature Communications · doi:10.1038/ncomms10331 · Cited by 625 · cited 1×
“For computational validation, a straightforward way is to assess AUROC values as well as specificity, sensitivity and positive predictive value (PPV).[41] In addition, recall and precision can be computed to obtain the precisionrecall curve (PRC),[42] followed by the area under this curve (AUPRC).”
MethodAliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 605
Menden, M. P., Iorio, F., Garnett, M., McDermott, U., Benes, C. H., Ballester, P. J., & Saez-Rodriguez, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061318 · Cited by 542
Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings, W. C., Connolly, D. T., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010548w · Cited by 462
Jin, G., & Wong, S. T. C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.005 · Cited by 416
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Shim, J. S., & Liu, J. O. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9224 · Cited by 382
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X.-L., & Zheng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 382
Deep Learning for Drug-Induced Liver Injury
Xu, Y., Dai, Z., Chen, F., Gao, S., Pei, J., & Lai, L. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00238 · Cited by 382
Challenges and opportunities of drug repositioning
Novac, N. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.004 · Cited by 374
Drug repositioning: a machine-learning approach through data integration
Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D’Amato, M., & Greco, D. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-30 · Cited by 349
In silico methods for drug repurposing and pharmacology
Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1337 · Cited by 326
Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
Drug repositioning for personalized medicine
Li, Y. Y., & Jones, S. J. (2012) · Genome Medicine · doi:10.1186/gm326 · Cited by 248
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 241
Transcriptional data: a new gateway to drug repositioning?
Iorio, F., Rittman, T., Ge, H., Menden, M., & Saez-Rodriguez, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.014 · Cited by 237
Literature mining, ontologies and information visualization for drug repurposing
Andronis, C., Sharma, A., Virvilis, V., Deftereos, S., & Persidis, A. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr005 · Cited by 234
Khatri, P., Roedder, S., Kimura, N., De Vusser, K., Morgan, A. A., Gong, Y., Fischbein, M. P., Robbins, R. C., Naesens, M., Butte, A. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122709 · Cited by 232
Drug repositioning for orphan diseases
Sardana, D., Zhu, C., Zhang, M., Gudivada, R. C., Yang, L., & Jegga, A. G. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr021 · Cited by 228
Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M., Shah, A., Han, X., Ruan, X., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 218
Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review
Luo, Y., Thompson, W. K., Herr, T. M., Zeng, Z., Berendsen, M. A., Jonnalagadda, S. R., Carson, M. B., & Starren, J. (2017) · Drug Safety · doi:10.1007/s40264-017-0558-6 · Cited by 200
In silico drug repositioning – what we need to know
Liu, Z., Fang, H., Reagan, K., Xu, X., Mendrick, D. L., Slikker, W., & Tong, W. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.08.005 · Cited by 183
Assessing Drug Target Association Using Semantic Linked Data
Chen, B., Ding, Y., & Wild, D. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002574 · Cited by 166
Computational drug repositioning through heterogeneous network clustering
Wu, C., Gudivada, R. C., Aronow, B. J., & Jegga, A. G. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s5-s6 · Cited by 166
The challenges, advantages and future of phenome‐wide association studies
Hebbring, S. J. (2014) · Immunology · doi:10.1111/imm.12195 · Cited by 164
Wang, Y., Chen, S., Deng, N., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078518 · Cited by 163
Mining small-molecule screens to repurpose drugs
Swamidass, S. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr028 · Cited by 115
Jin, G., Fu, C., Zhao, H., Cui, K., Chang, J. C., & Wong, S. T. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2333 · Cited by 99
How to Revive Breakthrough Innovation in the Pharmaceutical Industry
Munos, B. H., & Chin, W. W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002273 · Cited by 95
Toxicity Prediction using Deep LearningPreprint
Unterthiner, T., Mayr, A., Klambauer, G., & Hochreiter, S. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1503.01445 · Cited by 86
Liu, Z., Guo, F., Gu, J., Wang, Y., Li, Y., Wang, D., Lu, L., Li, D., & He, F. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv055 · Cited by 75
Systematic Drug Repurposing Through Text Mining
Tari, L., & Patel, J. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0709-0_14 · Cited by 65
Challenges and perspective of drug repurposing strategies in early phase clinical trials
Kato, S., Moulder, S. L., Ueno, N. T., Wheler, J. J., Meric‐Bernstam, F., Kurzrock, R., & Jankú, F. (2015) · Oncoscience · doi:10.18632/oncoscience.173 · Cited by 58
Zhu, Q., Tao, C., Shen, F., & Chute, C. G. (2013) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814583220_0017 · Cited by 55
Jadamba, E., & Shin, M. (2016) · BioMed Research International · doi:10.1155/2016/7147039 · Cited by 55
A phenome-guided drug repositioning through a latent variable model
Bişğin, H., Liu, Z., Fang, H., Kelly, R. J., Xu, X., & Tong, W. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-267 · Cited by 50
Drug interaction networks: an introduction to translational and clinical applications
Azuaje, F. J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs289 · Cited by 48
Recommendation Techniques for Drug–Target Interaction Prediction and Drug Repositioning
Alaimo, S., Giugno, R., & Pulvirenti, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3572-7_23 · Cited by 44
Loi, T. H., Campain, A. E., Bryant, A. J., Molloy, T., Lutherborrow, M. A., Turner, J., Yang, J. Y. H., & David, D. F. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-27 · Cited by 25
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763201 · Cited by 380
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
Pillaiyar, T., Meenakshisundaram, S., Manickam, M., & Sankaranarayanan, M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112275 · Cited by 140
Koromina, M., Pandi, M.-T., & Patrinos, G. P. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0151 · Cited by 140
Metadata
- Authors
- Park, K.
- Venue
- Translational and Clinical Pharmacology
- Publisher
- XMLink
- Published
- 2019
- Volume
- 27
- Issue
- 2
- Pages
- 59
- ISSN
- 2289-0882 (ISSN-L)
- 2383-5427
- OpenAlex
- W2959798450
- Cited by
- 300
- References
- 47
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.